SCHEMBL24250206

SCHEMBL24250206

BC(C)(C)c1cc(-c2ccccc2)ncc1S(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LDHA P00338 1/20 0.39
▸ NPC1 O15118 3/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ IDO1 P14902 3/20 0.36
▸ TDO2 P48775 3/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ GSK3A P49840 1/20 0.35
▸ GSK3B P49841 1/20 0.35
▸ CYP11B1 P15538 2/20 0.35
▸ CYP11B2 P19099 2/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ ASIC3 Q9UHC3 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ MIF P14174 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ CTDSP1 Q9GZU7 1/20 0.34
▸ PDGFRB P09619 1/20 0.34
▸ KDR P35968 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24118655 0.88 LDHA (0.37) LDHANPC1RAB9AIDO1TDO2
SCHEMBL22080319 0.83 LDHA (0.42) LDHANPC1RAB9AIDO1TDO2
SCHEMBL26651175 0.82 LDHA (0.40) LDHANPC1RAB9AIDO1TDO2
SCHEMBL24533913 0.80 KMO (0.36) LDHANPC1RAB9AIDO1TDO2
SCHEMBL24631934 0.79 LDHA (0.37) LDHANPC1RAB9AIDO1TDO2
SCHEMBL23106483 0.78 LDHA (0.44) LDHANPC1RAB9AIDO1TDO2
SCHEMBL20272726 0.77 LDHA (0.42) LDHANPC1RAB9AIDO1TDO2
SCHEMBL23001269 0.77 LDHA (0.54) LDHANPC1RAB9AIDO1TDO2
SCHEMBL25472715 0.77 TDO2 (0.32) TDO2
SCHEMBL25472621 0.76 LDHA (0.40) LDHANPC1RAB9AIDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220052278-A1 DISPLAY APPARATUS SAMSUNG DISPLAY CO., LTD. (KR) 2022-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220052278-A1 DISPLAY APPARATUS OCIAD1, OCIAD2, COG4 LDHA 1226/4885NPC1 2515/4885RAB9A 3137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback